| |
CNV = 2, (N = 31)
|
CNV > 2, (N = 4)
|
P value
|
|---|
|
Age at diagnosis (years)
|
60.48 ± 16.76
|
57.5 ± 10.88
|
0.808
|
|
Menopausal status
|
0.458
|
|
Premenopausal
|
25.8%
|
0%
|
|
Perimenopausal
|
3.2%
|
0%
|
|
Menopausal
|
71.0%
|
100%
|
|
Estrogen receptor
|
0.523
|
|
Positive
|
83.9%
|
100%
|
|
Negative
|
16.1%
|
0%
|
|
Progesterone receptor
|
0.454
|
|
Positive
|
86.2%
|
100%
|
|
Negative
|
19.4%
|
0%
|
|
HER-2 status
|
0.082
|
|
Positive
|
74.2%
|
25%
|
|
Negative
|
25.8%
|
75%
|
|
Palpable tumour
|
0.601
|
|
Yes
|
87.1%
|
100%
|
|
No
|
12.9%
|
0%
|
|
Lymph node status
|
0.082
|
|
Negative
|
25.8%
|
75%
|
|
Positive
|
74.2%
|
25%
|
|
Tumour type
|
0.791
|
|
Invasive ductal carcinoma (IDC)
|
80.6%
|
75%
|
|
Ductal carcinoma in situ (DCIS)
|
0%
|
0%
|
|
Lobular
|
19.4%
|
25%
|
|
D & L
|
0%
|
0%
|
|
Other
|
0%
|
0%
|
|
Histological grade
|
0.304
|
|
I
|
9.7%
|
0%
|
|
II
|
35.5%
|
75%
|
|
III
|
54.8%
|
25%
|
|
Location
|
0.114
|
|
Unilateral
|
100%
|
75%
|
|
Bilateral
|
0%
|
25%
|
|
Familial history
|
< 0.001
|
|
Yes
|
6.5%
|
100%
|
|
No
|
93.5%
|
0%
|
|
Size
|
0.530
|
|
< 2 cm
|
38.7%
|
50%
|
|
> 2 cm
|
61.3%
|
50%
|
|
Vascular invasion
|
0.553
|
|
Yes
|
29%
|
0%
|
|
No
|
71%
|
100%
|
